Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CHDEN 29920, D0117439000 | Other Identifier | Dental Foundation of North Carolina, Inc. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dental Foundation of North Carolina, Inc. | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anecdotal reports suggest buffering lidocaine with epinephrine just before intraoral injection reduces time of onset, results in a deeper anesthetic effect, without the "sting" with injection from a low pH. Additional data are needed to establish clinical important outcomes such as the peak blood level of lidocaine as compared to the non-buffered drug combination.
Clinical pilot studies are proposed as the start of a series of investigations to support or modify the use of the buffered anesthetic for intraoral procedures.
Specific Aims:
Compare blood levels at 30min post injection mandibular block with buffered and non- buffered 2% lidocaine with 1/100k epinephrine. Assess outcomes (pain levels during and post-injection, and onset of anesthesia symptoms) after buffered and non-buffered oral administration of 2% lidocaine with 1/100k epinephrine. Assess possible topical anesthetic properties of buffered and non-buffered oral administration of 2% lidocaine with 1/100k epinephrine
Hypotheses:
No difference in peak blood levels exist between buffered and non-buffered intraoral injection of 2% lidocaine with 1/100k epinephrine.
Injection of buffered local anesthetic will produce less discomfort for the subject as compared to the drug with a low pH.
Buffered local anesthetic will not produce a topical anesthetic effect
Study Time Frame: 6 months Month One IRB approvals. Recruit volunteers as subjects. Prepare case-books. Months Two-Three Clinical Study Months Four-Five Analyze Lab, QOL data Month Six Prepare Abstracts, Papers
Methods: Blinded, Randomized Clinical Design Recruit subjects with IRB approved consent at UNC Target enrollment 24 subjects Subjects will serve as their own controls in a cross-over AB/BA study design which is uniform within sequences, uniform within periods, and balanced Sample size justification: Primary interest is estimation of effect size from pilot study. 24 subjects should be sufficient to provide data to assess whether a larger study is warranted and provide estimates for sample size calculation for larger studies. Vital signs recorded: 10 min before, during at 30min intervals and after post-anesthetic clinical signs disappear: targeted lower lip no longer numb. Randomized subjects to be injected alternatively with 4cc of buffered and 4cc non-buffered oral administration of 2% lidocaine with 1/100k epinephrine.
SAS will be used to create randomization schedules:
The randomization will be performed first to type of drug given with a balanced randomization (half subjects buffered; half to non-buffered) An OMS resident, Dr Phero, will administer the drugs in the OMS clinic.
In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. At least a week later injections would involve the alternate local anesthetic combination.
Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels Timed Assessment: pre, during injection, and post-anesthetic for Clinical Onset of Anesthesia Signs: subject reported molar area numbness and numb lower lip on ipsilateral injected side. Assessment for pain level on injection; modified Likert-type scale
In addition at each clinic session an assessment of a topical anesthetic effect on contralateral lower lip with 5 drops of the injected drug placed on the clinically dry lower lip mucosa, Outcome yes/no.
Data Collection: UNC OMS clinic Venous blood samples (10cc) will be drawn from the antecubital fossa 30min post oral injection. Timed assessment pre, during injection, and post-anesthetic clinical Signs: molar area anesthesia, incisor area anesthesia, and numb lower lip for topical
Data Collection/Analysis:
Data will be managed by study staff. Data collection forms and questionnaires for clinical data will be developed to use Teleform for direct scanning input into an ACCESS database. Similar forms have been used in previous studies. All databases are stored on a password protected School of Dentistry server with specific group assignment. SAS will be used for database management and statistical analysis. Descriptive statistics are used to verify correct entry through range and logical checks.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Buffered Lidocaine | Active Comparator | In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels |
|
| Non-buffered Lidocaine | Active Comparator | In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. At least a week later injections would involve the alternate local anesthetic combination. Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lidocaine | Drug | See above |
|
| Measure | Description | Time Frame |
|---|---|---|
| Lidocaine Blood Levels 30 Minutes Post Injection | Lidocaine blood levels were obtained 30 minutes post injection micro g/L The difference between injection type- 95% confidence intervals for the difference between injection types was calculated. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered, was performed using Wilcoxon rank sum tests with Proc NPAR1WAY (SAS v 9.3). Statistical significance was set as P < 0.05 for all outcomes. | 30 minutes post injection |
| Measure | Description | Time Frame |
|---|---|---|
| Pain Intensity Scores | Patients reported pain level immediately after injection of lidocaine via a Likert type scale where 1 = No Pain and 10 = Worst Pain Imaginable. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered was performed. | Immediately after lidocaine injection |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Raymond P White, Jr, DDS, PhD | University of North Carolina, Chapel Hill | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UNC School of Dentistry | Chapel Hill | North Carolina | 27599-7450 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27815105 | Result | Phero JA, Nelson B, Davis B, Dunlop N, Phillips C, Reside G, Tikunov AP, White RP Jr. Buffered Versus Non-Buffered Lidocaine With Epinephrine for Mandibular Nerve Block: Clinical Outcomes. J Oral Maxillofac Surg. 2017 Apr;75(4):688-693. doi: 10.1016/j.joms.2016.09.055. Epub 2016 Oct 8. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
No enrolled subjects excluded.
Beginning in December 2015 23 subjects recruited for study conducted in the surgery clinic at UNC School of Dentistry
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Buffered Lidocaine, Then Non-buffered Lidocaine | At Visit 1 each subject received Buffered Lidocaine anesthetic to block the inferior alveolar and lingual N; using Halstead or Gow-Gates techniques. No Buccal N. block. Venous blood samples were drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels. Following a 2-week washout, subjects received Non-buffered Lidocaine in the same fashion at Visit 2. |
| FG001 | Non-buffered Lidocaine, Then Buffererd Lidocaine | At Visit 1 each subject received Non-Buffered Lidocaine anesthetic to block the inferior alveolar and lingual N; using Halstead or Gow-Gates techniques. No Buccal N. block. Venous blood samples were drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels. Following a 2-week washout, subjects received Buffered Lidocaine in the same fashion at Visit 2. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Intervention (Visit 1) |
| |||||||||||||
| Washout (2 Weeks) |
| |||||||||||||
| Second Intervention (Visit 2) |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Study Participants | Subjects who were randomized to receive either Buffered or Non-Buffered Lidocaine |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Lidocaine Blood Levels 30 Minutes Post Injection | Lidocaine blood levels were obtained 30 minutes post injection micro g/L The difference between injection type- 95% confidence intervals for the difference between injection types was calculated. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered, was performed using Wilcoxon rank sum tests with Proc NPAR1WAY (SAS v 9.3). Statistical significance was set as P < 0.05 for all outcomes. | Posted | Mean | Standard Deviation | ug/L | 30 minutes post injection |
|
two weeks
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Buffered Lidicaine | In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels Lidocaine: See above |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr Raymond P. White Jr | University of North Carolina Chapel Hill | 919-537-3944 | ray_white@unc.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Oct 30, 2015 | Oct 31, 2017 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D008012 | Lidocaine |
| ID | Term |
|---|---|
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of Minutes to Anesthesia Symptoms of Lower Lip | Patients were instructed to record the time when they experienced the initial indication of anesthesia signs in the lower lip. This was reported as the number of minutes following nerve block injection. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered was performed. | Patient report of anesthesia symptom onset following injection |
| Topical Anesthesia Effect Contralateral Lower Lip | Investigator will administer 5-6 drops of the lidocaine to the contralateral lower lip and immediately ask if signs of numbness are present on the lip. Patients reported presence of numbness lower lip-Yes or No | At time of administration |
| NOT COMPLETED |
|
| NOT COMPLETED |
|
| Participants |
|
| Age, Continuous | Median | Inter-Quartile Range | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
|
|
|
| Secondary | Pain Intensity Scores | Patients reported pain level immediately after injection of lidocaine via a Likert type scale where 1 = No Pain and 10 = Worst Pain Imaginable. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered was performed. | Posted | Mean | Standard Deviation | units on a scale | Immediately after lidocaine injection |
|
|
|
|
| Secondary | Number of Minutes to Anesthesia Symptoms of Lower Lip | Patients were instructed to record the time when they experienced the initial indication of anesthesia signs in the lower lip. This was reported as the number of minutes following nerve block injection. For the outcome variable, an assessment of treatment difference by subject, calculated as 1% Buffered minus 2% Non-Buffered was performed. | Posted | Mean | Standard Deviation | minutes | Patient report of anesthesia symptom onset following injection |
|
|
|
|
| Secondary | Topical Anesthesia Effect Contralateral Lower Lip | Investigator will administer 5-6 drops of the lidocaine to the contralateral lower lip and immediately ask if signs of numbness are present on the lip. Patients reported presence of numbness lower lip-Yes or No | Unable to administer in this fashion because Lidocaine would not remain on lip surface therefore data were not collected | Posted | At time of administration |
|
|
| 0 |
| 23 |
| 0 |
| 23 |
| 0 |
| 23 |
| EG001 | Non-bufered Lidocaine | In week One each subject would receive anesthetic to block the inferior alveolar and lingual N; Halstead or Gow-Gates techniques. No Buccal N. block. At least a week later injections would involve the alternate local anesthetic combination. Venous blood samples would be drawn from the antecubital fossa 30min post oral injection and assayed for blood lidocaine levels Lidocaine: See above | 0 | 23 | 0 | 23 | 0 | 23 |
Not provided
Not provided
| Aniline Compounds |
| D000588 | Amines |